Skip to main content

Legal Capsule by Economic Law Practice


Implications of the WTO Panel’s Decision: India – Export Related Measures (DS541)

BACKGROUND
 
On October 31, 2019, a WTO Panel issued its report in the dispute India – Export Related Measures (DS541), finding that a number of incentives provided by the Indian Government, under various export promotion  schemes, violated certain WTO disciplines. The complaint which was initiated against India by the United States challenged the following schemes:
  • Export Oriented Units and Sector-Specific Schemes (EOU/EHTP/BTP)
  • Merchandise Exports from India Scheme  (MEIS)
  • Export Promotion Capital Goods  (EPCG) Scheme
  • Special Economic Zones (SEZ) Scheme
  • Duty Free Imports for Exporter Scheme (DFIS)
  • Depending upon the scheme in question, an eligible participant, may be entitled to the following incentives:
  • Exemptions from customs duties  on importation of various goods (including raw materials and capital goods)
  • Exemption from central excise duty payable on “excisable goods”, IGST and compensation cess
  • Duty credit scrips adjustable against customs duties, central excise duties and certain other charges owed to the Indian Government
  • Deduction of export earnings from corporate income taxes
The United States challenged the above incentives as ‘prohibited export subsidies’ under Article 3.1(a) and Article 3.2 of the WTO Agreement on Subsidies and Countervailing Measures (ASCM).
 
KEY LEGAL PROVISIONS AT ISSUE IN THE DISPUTE
This dispute examined whether the incentives provided by India’s export promotion schemes were prohibited under the WTO framework and if so, whether they could be covered by any of the exceptions as claimed by India under the ASCM. Separately the dispute also examined whether India, as a developing country, could avail of special benefits under the ASCM to protect its export promotion schemes.

A subsidy under the ASCM refers to a financial contribution by a government or public body that confers a benefit. Subsidises that are contingent, in law or in fact, on export performance are ‘prohibited’ under the ASCM.

However, footnote 1 to the ASCM provides a carve-out from the definition of a subsidy. It states that a measure is not a subsidy if it provides exemption or remission of duties or taxes (on an exported product) not in excess of duties and  taxes actually accrued, or those levied on like products for domestic consumption. Read with Annex I of the ASCM, the following exemptions on certain taxes, if not in excess of those levied on good for domestic consumption, may not be considered export subsidies:
  • Exemption or remission of “indirect taxes” with respect to production and distribution of exported products [Annex I(g)]
  • Exemption, remission or deferral of prior-stage cumulative “indirect taxes” on goods and services used the production of exported products [Annex I(h)]
  • Remission or drawback of “import charges” on imported “inputs” consumed in the production of the exported products [Annex I(i)]
KEY FINDINGS OF THE PANEL

Special and differential treatment for developing countries

Annex VII of the ASCM allows certain developing countries, including India, to maintain export subsidies, provided that the per capita income of these countries does not cross 1000 USD for three consecutive years. The ASCM does not expressly provide for treatment of these countries once they cross the said threshold. Notably, Article 27.2(b) of the ASCM provides for a phase out period of 8 years from entry into force of the WTO agreement for ‘other’ developing countries (i.e. developing countries that are not listed   in Annex VII) to discontinue prohibited ‘export subsidies’.

India crossed this threshold in 2016, however India argued before the Panel that it was still entitled to maintain its export subsidies because it was entitled to the 8 year phase out period (from the date of graduation from Annex VII) like the other  developing countries.

The Panel however rejected India’s argument as a textual interpretation of Article 27.2 read with Annex VII did not support India’s claims61.

Customs Duty Exemptions on Capital Goods 

In examining whether the customs duty exemptions provided on the import  of  various goods under the EPCG, EOU and DFIS Schemes were export subsidies, the Panel considered whether they were covered under the exception in Annex I(i) of the ASCM.

The Panel found that the import duty exemptions on capital goods did not meet the conditions of Annex I(i) as capital goods do not constitute inputs consumed in the production process as they are not physically incorporated in the goods or services they are used to produce nor are they physically present in the final product.62 Furthermore, the Panel found that these exemptions were prohibited export subsidies as they were export contingent.

However, the duty exemptions on raw materials under the EOU/EHTP/BTP  and DFIS Schemes were found to be within the scope of Annex I(i) since they constituted inputs.

Central Excise, IGST and Compensation Cess Exemptions

India argued that the exemption from central excise duties under the EOU/EHTP//BTPs scheme met the conditions of footnote 1 read together with Annex I(h) as exemptions remission or deferral of prior-stage indirect taxes levied on inputs.

The Panel noted that the exemption applied  to procurement of “excisable goods” were in the nature of inputs and hence these exemptions (which were not in excess of  those   levied   upon   goods   for   home market consumption) were not prohibited export subsidies.

Separately, the exemption from certain other indirect taxes namely, IGST and compensation cess under the EOU/EHTP/BTP and EPCG Scheme were not examined by the Panel because they were not elaborated upon by the United States.63

Duty Credit Scrips
India argued that the scrips issued under the MEIS constituted refunds for past  payments of indirect taxes, under footnote 1 read together with Annexes I(g) and I(h). The US argued that there was no connection with the taxes actually paid and the value of the scrips.

The Panel rejected India’s arguments noting that, as per the Foreign Trade Policy, duty credit scrips were granted as a “reward” for exports.65 The Panel further noted that the basis for calculating the reward was the free on board value of past exports of notified goods to notified markets which was then multiplied by a variable applicable rate of reward for each  product-country combination. This did not indicate that indirect taxes paid in connection with the exported products were the basis of the award of MEIS scrips.66 Furthermore, the Panel found the scheme to be a prohibited subsidy as it was export contingent.

The SEZ Scheme

India did not claim the exceptions under footnote 1 read with annex 1 with respect to the exemptions provided under the SEZ Scheme. The Panel found the benefits provided under the scheme with respect to exemptions on import duties and IGST and deductions from corporate income tax, to be entirely inconsistent with the ASCM as they were export contingent.

CONCLUSION: IMPLICATIONS OF THE PANEL’S FINDINGS

With India choosing to appeal the report of the Panel and the current impasse surrounding the functioning of the Appellate Body, it is unclear as  to when and how this report will be adopted. That said, the findings of the Panel in this case may have implications on the WTO-consistency of several export promotion schemes maintained by several Members of the WTO. Given this context, key implications of the Panel’s decision are provided below:
  • The Panel’s clarification regarding special and differential treatment makes it clear that developing countries listed in Annex VII will be subject to the prohibitions of Article 3 of the ASCM immediately after they graduate from Annex VII.
  • Export Promotion Schemes that provide exemptions from import charges on import of capital goods cannot be protected under the exceptions to the ASCM. However, the Panel did not examine whether exemptions on indirect taxes levied on the import of capital  goods  could possibly be covered under Annex I(g).
  • The Panel’s findings regarding the SEZ Scheme may have implications on similar Export Processing Zones existing in several other countries that provide fiscal benefits to entities operating from such Export Processing Zones.
Finally, it is possible to structure export subsidies so that they are compatible with WTO rules and governments  may  consider  rejigging  their  Export  Promotion   Schemes   based   on   the needs of  the  businesses  and  industry.  In  fact,  the Government of India (GoI) has proposed to replace the MEIS by another scheme namely, Remission  of  Duties  or  Taxes  on   Export Product  which   aims   to   offer   refund   of   certain non-creditable  indirect  taxes  levied  at  the central and state levels.68 Similarly, the  GoI  had  also  constituted  a  committee  headed  by   Mr.  Baba  Kalyani  to  review  the  special economic zones policy of India. The committee has submitted its report to the GoI (not yet available   in public domain).69 It is unclear if the committee has investigated the WTO  issues  while formulating the report. Given that the GoI appears to be keen in reforming its export promotion policies, it would be  useful  for  businesses  to make sound representations to the GoI for formulating WTO-compliant policies.

Popular posts from this blog

EY Tops League Table for Transaction Advisors to M&A deals in 24

Moelis & Company & PwC claim the No.2 & No.3 slots Ernst & Young  (EY) topped the Venture Intelligence League Table for Transaction Advisor to M&A Deals   during 2024, advising 34 deals worth $4.1 Billion. Moelis & Company stood second advising 2 deals worth $3.9 billion. PwC followed with 18 deals worth $3.3 billion. Citi ($2.5 billion across 1 deal) and Advay Capital ($2.3 billion across 1 deal) completed the top five. Among the largest M&A deals in 2024, Citi  advised $2.5 Billion acquisition of the Indian business of American Tower Corporation by Brookfield , Advay Capital and Moelis & Company advised the $2.3 Billion acquisition of Care Hospitals by Aster DM Healthcare . Jefferies & Co., JP Morgan and Moelis & Company advised the $1.6 Billion acquisition of Bharat Serums & Vaccines by Mankind Pharma.  Among the other notable M&A deals in Q4 2024, EY advised the $685 million acquisition of ITD Cementation ...

Morgan Stanley tops League Table for Transaction Advisors to M&A deals in 2020

Morgan Stanley , which advised the $10.1 Billion strategic investment by Facebook and Google into Reliance Industries' telecom arm Jio platforms (among other Private Equity investments in the company), topped the Venture Intelligence League Table for Transaction Advisor to M&A Deals for 2020. Ambit Corporate Finance - which advised 3 deals worth $4.0 Billion, including Brookfield's $3.7 Billion acquisition of Reliance Tower Infrastructure Trust -  took the second spot. JM Financial ($3.7 Billion across 5 deals), Metta Capital ($3.4 Billion across 3 deals) and ICICI Securities ($3.4 Billion across 2 deals) - all of whom (along with Citi) are advisors to the $3.4 Billion acquisition of Future Group's retail related ventures by Reliance Retail, announced in August - completed the top five. The  Venture Intelligence League Tables , the first such initiative exclusively tracking transactions involving India-based companies, are based on the value of PE and M&A tra...

Everything you wanted to know (and some things you didn't care to know) about ChrysCapital's Ashish Dhawan

New Delhi-based private equity fund ChrysCapital is vastly different from its former avatar, Chrysalis Capital. While Chrysalis began life (in Mumbai) as an venture capital firm focussed on start-up investments, today's ChrysCapital is best know for its late-stage investments (often in already public companies). The fascinating part of this transformation is that one of the fund's original partners - Senior Managing Director Ashish Dhawan - has been firmly in the driver's seat throughout the process. It's a story that needed to be told. As a cover story. Kudos to Business Today for telling it first. Thankfully, unlike the glowing profiles that BT is famous for - including the one featuring infamous stock brocker Harshad Mehta with his Lexus on the cover - this one has a lot of facts. Some well known. And others less so. That ChrysCapital's first fund would have been a disaster but for the pioneering investment in Raman Roy founded BPO firm Spectramind i...

Why did Sony Entertainment Television's CEO quit?

Businessworld has a cover story on the corporate battle that resulted in Kunal Dasgupta, the CEO of Multi Screen Media (formerly Sony Entertainment Television), quitting just a few months before his contract was due to end. Dasgupta’s abrupt exit was the culmination of six years of tension between majority shareholder Sony Pictures Television International (SPTI) that owns 61 per cent of MSM, on one hand, and Atlas Equifinn on the other, which is a consortium of Indian shareholders (Singapore-based Rakesh Aggarwal, World Media Group director Sudesh Iyer, Shemaroo Entertainment Managing Director Raman Maroo, MobiApps Holding’s Jayesh Parekh, B.R. Sule, Sushil Shergil and actor Jackie Shroff ) holding 32 per cent. Capital Japan and some financial institutions own the rest 7 per cent. And of course, the third protagonist is Dasgupta, who walked a tightrope and managed to keep his job for over 14 years despite the fact that neither group of shareholders was too happy with him. Very little...

APEX VC Awards: Chiratae Ventures, Blume Ventures, Elevation Capital, Stride Ventures & Alteria Capital judged best funds of 2021

Press Release Elevation Capital , Chiratae Ventures , Blume Ventures , Stride Ventures and Alteria Capital were voted the top Venture Capital investors in India during 2021. The Venture Intelligence “Awards for Private Equity Excellence” (APEX) is dedicated to celebrating the best that the Indian Private Equity & Venture Capital industry has to offer. "VCs exist because Entrepreneurs exist and disrupt the ecosystem by creating new businesses. We are very excited to be part of the secular trend of tech disruption that would power India’s journey towards $ 10 Trillion economy over the next decade," said  T C Meenakshi Sundaram, Founder & Vice Chairman, Chiratae Ventures , winner of " VC Fund raise of the Year " award.  " We wish to thank all our entrepreneurs who have chosen to take funding from Chiratae Ventures and investors who have backed us with funds over the past 15 years in this journey.  Congratulations to the entire Chiratae Ventures team and ...